Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA
Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )
9 May 2019

State of art in systemic management of nmCRPC

Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France
State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )
8 May 2019

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )
8 May 2019

Surgical management of pancreatic cancer

Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia
Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )
8 May 2019

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019

Treating ovarian cancer patients with PARP inhibitors

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019

Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019

Benefits of cannabis legalisation to patients and oncology professionals

Eloise Theisen - Radicle Health, Walnut Creek, USA
Benefits of cannabis legalisation to patients and oncology professionals ( Eloise Theisen - Radicle Health, Walnut Creek, USA )
8 May 2019

Cancer immunotherapy for the advanced practice nurse

Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA
Cancer immunotherapy for the advanced practice nurse ( Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA )
8 May 2019

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA
Pharmacology update from ONS 2019 ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )
8 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation